Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2006-08-04Clinical Trial Update: Depakote ER Plus an Atypical Antipsychotic Vs. an Atypical Antipsychotic Alone in the Treatment of Schizophrenia [Phase 2]
A Phase 2 trial by Abbott evaluated adding Depakote ER to an atypical antipsychotic versus an atypical antipsychotic alone for schizophrenia…
-
CLINICAL_TRIALS trial_result · 2006-07-25Clinical Trial Update: A First In Human Study Of PF-00184562 In Healthy Volunteers [Phase 1]
Pfizer completed a first-in-human Phase 1 study of PF-00184562 in healthy volunteers to evaluate safety, tolerability and pharmacokinetics, …
-
CLINICAL_TRIALS trial_result · 2006-07-20Clinical Trial Update: A Combination of Two Currently Approved Drugs to Enhance the Treatment of Schizophrenia [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial from Eli Lilly evaluating a combination of two approved drugs to enhance treatment of schizophrenia.
-
CLINICAL_TRIALS trial_result · 2006-07-19Clinical Trial Update: Olanzapine Versus An Active Comparator in the Treatment of Schizophrenia [Phase 4]
Phase 4 trial comparing olanzapine to an active comparator in schizophrenia has completed, evaluating efficacy and safety outcomes. The tria…
-
CLINICAL_TRIALS trial_result · 2006-07-19Clinical Trial Update: Pharmacokinetic Characterization of Intramuscular Olanzapine Depot [Phase 1]
Phase 1 clinical trial update characterizing the pharmacokinetics of intramuscular olanzapine depot (olanzapine pamoate) in schizophrenia an…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2006-07-19Clinical Trial Update: Olanzapine Versus Active Comparator in the Treatment of Depression in Patients With Schizophrenia [Phase 4]
A Phase 4 trial comparing olanzapine to an active comparator in depression associated with schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2006-07-19Clinical Trial Update: The Assessment of a Weight-Gain Agent for the Treatment of Olanzapine-Associated Anti-Obesity Agent in Patients With Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, and Bipolar I Disorder [Phase 4]
Phase 4 trial completed evaluating a weight-gain agent for treating olanzapine-associated weight gain in patients with schizophrenia, schizo…
-
FDA approval · 2006-06-22FDA Approved: PERPHENAZINE — Supplemental Application (Endo USA, Inc.)
FDA approved a supplemental application for Perphenazine (Endo USA, Inc.).
-
CLINICAL_TRIALS trial_result · 2006-05-31Clinical Trial Update: Risperidone and Olanzapine for the Schizophrenic Patients With Neuroleptic-Induced Acute Dystonia or Parkinsonism [Phase 4]
Phase 4 clinical trial evaluating risperidone and olanzapine for schizophrenia patients with neuroleptic-induced acute dystonia or Parkinson…
-
CLINICAL_TRIALS trial_result · 2006-05-22Clinical Trial Update: Effect of Specific Anti-Toxoplasmatic Add-on Medication in Toxoplasma Gondii Seropositive Individuals With Schizophrenia or Major Depression [Phase 3]
A Phase 3 trial evaluating an anti-Toxoplasma gondii add-on therapy in Toxoplasma seropositive individuals with schizophrenia or major depre…
-
CLINICAL_TRIALS trial_result · 2006-05-19Clinical Trial Update: Sarcosine (N-Methylglycine) Monotherapy for Schizophrenia [Phase 2]
A Phase 2 trial evaluating sarcosine as a monotherapy for schizophrenia has been completed.
-
CLINICAL_TRIALS trial_result · 2006-05-08Clinical Trial Update: CARE Study: Improving Treatment for the Most Severely Ill With Schizophrenia [Phase 4]
CARE, a Phase 4 trial sponsored by the University of British Columbia, evaluating treatment for the most severely ill patients with schizoph…
-
CLINICAL_TRIALS trial_result · 2006-05-03Clinical Trial Update: D-Serine Monotherapy for Schizophrenia [Phase 1, Phase 2]
D-Serine monotherapy is being studied for schizophrenia in Phase 1 and Phase 2 trials; the current status of the trial is unknown.